- Free from Publisher JP Baillargeon, E Diamanti-Kandarakis, RE … - Diabetes care, 2006 - Am Diabetes Assoc RESULTS—Women with PCOS were heavier than control subjects (P = 0.002 for
BMI), but also had decreased S i (P < 0.001) and increased AUC insulin (P <
0.001) compared with normal women, even when corrected for BMI. The urinary ... Cited by 13 - Related articles - BL Direct - All 5 versions
S Gerli, M Mignosa, GC Di Renzo - European review for medical and pharmacological …, 2003 - europeanreview.org Polycystic ovary syndrome (PCOS) is a very common disorder of premenopausal
women characterized by hyperandrogenism and chronic anovulation1,2. Its etiology
is unknown. Although specific population-based studies have not been ... Cited by 10 - Related articles - View as HTML - BL Direct - All 3 versions
E Papaleo, V Unfer, JP Baillargeon, L De Santis … - Gynecological Endocrinology, 2007 - informahealthcare.com Background. Polycystic ovary syndrome (PCOS) is often characterized by chronic
oligo- or anovulation (usually manifested as oligo- or amenorrhea), and
hyperandrogenism. In addition, 30–40% of PCOS women have impaired glucose ... Cited by 5 - Related articles - BL Direct - All 7 versions
MJ Iuorno, MD, DJ Jakubowicz, MD, JP … - Endocrine Practice, 2002 - AACE The polycystic ovary syndrome is characterized by chronic anovulation and
hyperandrogenism. It is the most common cause of female infertility in the
United States and affects approximately 6 to 10% of women of child- bearing ... Cited by 24 - Related articles - BL Direct - All 2 versions
- ►oxfordjournals.org JP Baillargeon, JE Nestler, RE Ostlund, T … - Human Reproduction, 2008 - ESHRE RESULTS: PCOS women were heavier than controls (BMI = 28.4 versus 23.7 kg/m 2 ,
P = 0.05) with higher waist-to-hip ratios (WHR = 0.78 versus 0.71, P = 0.009)
and increased free testosterone (P = 0.048) and AUC insulin (P = 0.04). In ... Cited by 2 - Related articles - BL Direct - All 6 versions
- ►endojournals.org JP Baillargeon, MJ Iuorno, DJ Jakubowicz, T … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc Some actions of insulin are mediated by putative inositolphosphoglycan
mediators, and a deficiency in D-chiro-inositol-containing inositolphosphoglycan
(DCI-IPG) may contribute to insulin resistance in women with polycystic ... Cited by 28 - Related articles - BL Direct - All 5 versions
M Minozzi, G D'Andrea, V Unfer - Reproductive BioMedicine Online, 2008 - ingentaconnect.com Vittorio Unfer is a gynaecologist specializing in the fields of reproductive
endocrinology and clinical infertility for the last 15 years. He was born in
Rome in 1963. He received his MD from the Università di Roma 'La ... Cited by 2 - Related articles - All 2 versions
AD Genazzani, C Lanzoni, F Ricchieri, VM … - Gynecological Endocrinology, 2008 - informahealthcare.com Interventions. All patients underwent hormonal evaluations and an oral glucose
tollerance test (OGTT) before and after 12 weeks of therapy (Group A (n = 10):
myo-inositol 2 gr. plus folic acid 200 μg every day; Group B (n = 10): ... Cited by 3 - Related articles - BL Direct - All 5 versions
J Baillargeon - Current Opinion in Investigational Drugs, 2005 - biomedcentral.com Polycystic ovarian syndrome is a common disorder associated with a significant
long-term risk of developing type 2 diabetes and cardiovascular diseases.
Insulin resistance and hyperinsulinemia play an important role in its ... Cited by 20 - Related articles - View as HTML - BL Direct - All 3 versions
M Scioscia, A Vimercati, LE Selvaggi, CH … - Journal of Maternal-Fetal and Neonatal Medicine, 2006 - informahealthcare.com Methods. A prospective cross-sectional study was carried out to investigate IPG
P-type (P-IPG) in human amniotic fluid and in adult urine under physiological
conditions. An amniotic fluid sample was taken from 78 women undergoing ... Cited by 6 - Related articles - BL Direct - All 5 versions
